GlassScriptPhysician profile
Ruth Ann Pendergrast
NPI 1891185153
$9,033.85
in general payments reported to CMS, 2019-2025
37 companies · $1,975 in 2025
The $1,975 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,572 · 2022: $1,796 · 2023: $1,909 · 2024: $1,782 · 2025: $1,975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,666.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $774.26 | 2021-2025 | Uzedy, Austedo Xr |
| Sanofi-Aventis U.S. LLC | $516.69 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $510.58 | 2021-2023 | |
| Alexion Pharmaceuticals, INC. | $471.77 | 2022-2025 | |
| Novo Nordisk INC | $466.96 | 2022-2025 | Wegovy |
| Molnlycke Health Care US, LLC | $461.53 | 2021-2024 | Mepilex Border Sacrum, Mepilex Border Flex, Mlnlyckez-Flo Fluidized Positioner |
| Hollister Incorporated | $460.29 | 2021-2025 | Premier, New Image, Adapt Ceraring |
| Convatec INC. | $414.24 | 2022-2025 | |
| Medtronic, INC. | $405.43 | 2023-2025 | Interstim |
| Urgo Medical North America, LLC | $340.38 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Amgen INC. | $309.16 | 2021-2024 | Evenity, Repatha |
| Neurocrine Biosciences, INC. | $287.36 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $262.19 | 2022-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $258.28 | 2025 | |
| Gilead Sciences, INC. | $246.85 | 2024-2025 | Epclusa |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $245.60 | 2023-2024 | Rexulti |
| Pfizer INC. | $234.87 | 2024 | |
| Coloplast Corp | $191.75 | 2022-2023 | Sensura Mio |
| Hydrofera LLC | $183.87 | 2023-2024 | Hydrofera Blue |
| Astellas Pharma US INC | $181.89 | 2021-2024 | Veozah |
| Acadia Pharmaceuticals INC | $146.56 | 2021-2024 | Nuplazid |
| Inspire Medical Systems, INC. | $141.92 | 2023 | Inspire |
| Silk Road Medical, INC. | $141.60 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Abiomed | $139.15 | 2024 | Impella |
| Sk Life Science, INC. | $124.97 | 2023 | Xcopri |
| Jazz Pharmaceuticals INC. | $124.74 | 2025 | |
| Eisai INC. | $124.74 | 2024 | |
| Glaxosmithkline, LLC. | $121.83 | 2025 | Benlysta |
| Lundbeck LLC | $115.00 | 2023 | Vyepti |
| Viiv Healthcare Company | $107.10 | 2024 | Dovato |
| Janssen Pharmaceuticals, INC | $106.96 | 2025 | Spravato |
| Rhythm Pharmaceuticals, INC. | $103.19 | 2021 | |
| Kci USA, INC. | $83.99 | 2023 | 3m Cavilon, Promogran Prisma, Kerramax Care |
| Solventum Corporation | $82.22 | 2025 | Activ.A.C. |
| Cmp Pharma, INC. | $63.09 | 2022 | |
| Boston Scientific Corporation | $47.77 | 2021 | |
| Dexcom, INC. | $35.07 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Ann Pendergrast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.